Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

NCT04019548 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Cancer

Interventions

DEVICE: Percutaneous Endoscopic Gastrotomy tube placement
DRUG: Cisplatin injection
RADIATION: Radiotherapy

Sponsor

Jules Bordet Institute